iCAD (ICAD) – StreetInsider.com Reports
-
iCAD (ICAD) Tops Q4 EPS by 4c
-
iCAD (ICAD) Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
-
iCAD (ICAD) Appoints Hedvig Hricak to its Board
-
iCAD (ICAD) Appoints Michael J. Doyle to its Board
-
iCAD (ICAD) Tops Q3 EPS by 4c
-
iCAD (ICAD) Sells Xoft
-
iCAD (ICAD) Misses Q2 EPS by 1c, misses on revenue
-
iCAD (ICAD) Files $100M Mixed Shelf
-
icad Inc. (ICAD) PT Raised to $5 at Lake Street Capital Markets
-
iCAD (ICAD) call put ratio 9.5 calls to 1 put as share price increases 73%
-
iCAD (ICAD) Climbs 85% Following Strategic Commercial Agreement with Radiology Partners
-
icad Inc. (ICAD) PT Lowered to $2.50 at Craig-Hallum
-
iCAD (ICAD) Misses Q1 EPS by 3c
-
iCAD (ICAD) Announces Appointment of Chief Financial Officer and New Senior Executives
-
icad Inc. (ICAD) PT Lowered to $4 at JMP Securities
-
icad Inc. (ICAD) PT Lowered to $4 at Oppenheimer
-
icad Inc. (ICAD) PT Lowered to $2.50 at Lake Street Capital Markets
-
icad Inc. (ICAD) PT Lowered to $3 at Craig-Hallum
-
icad Inc. (ICAD) PT Lowered to $3 at BTIG
-
iCAD (ICAD) Tops Q4 EPS by 3c
-
iCAD (ICAD) Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
-
iCAD (ICAD) Announces Board of Directors Transition
-
iCAD (ICAD) and Google Health Ink Strategic Development and Commercialization Agreement
-
icad Inc. (ICAD) PT Lowered to $5 at Lake Street Capital Markets
-
icad Inc. (ICAD) PT Lowered to $4 at Craig-Hallum
-
icad Inc. (ICAD) PT Lowered to $6 at Oppenheimer
-
icad Inc. (ICAD) PT Lowered to $4 at BTIG
-
iCAD (ICAD) Misses Q3 EPS by 2c
-
iCAD (ICAD) and Solis Mammography Ink Deal to Collaborate on Use of AI to Evaluate Risk of Cardiovascular Disease
-
icad Inc. (ICAD) PT Lowered to $7 at JMP Securities
-
icad Inc. (ICAD) PT Lowered to $8 at Lake Street Capital Markets
-
icad Inc. (ICAD) PT Lowered to $6 at BTIG
-
iCAD (ICAD) Misses Q2 EPS by 1c
-
iCAD (ICAD) Announces CFO Transition
-
iCAD (ICAD) Announces Significant Commercial Momentum for ProFound AI Among Customers Equipped with the Leading Provider of 3D Mammography Systems
-
iCAD (ICAD) Reports Prelim Q1 Revenue of $7.5M, Announces Upcoming CFO Transition
-
icad Inc. (ICAD) PT Lowered to $13 at Lake Street Capital Markets
-
icad Inc. (ICAD) PT Lowered to $10 at Craig-Hallum
-
iCAD's (ICAD) Breast AI Platform Earns U.S. Department of Defense Authorization to Operate
-
Guggenheim Downgrades icad Inc. (ICAD) to Neutral
-
iCAD (ICAD) Appoints New Board Members
-
icad Inc. (ICAD) PT Lowered to $16 at Oppenheimer
-
icad Inc. (ICAD) PT Lowered to $13 at JMP Securities
-
iCAD (ICAD) CFO Buys 7K Shares
-
icad Inc. (ICAD) PT Lowered to $15 at Craig-Hallum
-
iCAD (ICAD) Appoints Stacey Stevens as Incoming CEO
-
icad Inc. (ICAD) PT Lowered to $22 at Oppenheimer
-
icad Inc. (ICAD) PT Lowered to $18 at JMP Securities
-
icad Inc. (ICAD) NDR Offers Confidence That 2Q Miss Will Not Be Repeated - Oppenheimer
-
iCAD (ICAD) Said to be Working with Bank to Explore Sale - Source
Back to ICAD Stock Lookup